The CML Content Hub Channel
Case Studies | Acute & Chronic Myeloid Leukemia | Redcliffe Labs
CML Content Hub
Yogitha Namasani, MD discusses two recent leukemia cases. The first involved a patient with acute leukemia diagnosed through peripheral smear, flow cytometry, and bone marrow studies, which confirmed…
Chronic Myelogenous Leukemia (CML) | Pathology of CML | Diagnosis and treatment of CML | USMLE
CML Content Hub
This is a comprehensive overview of Chronic Myelogenous Leukemia (CML), a rare type of cancer affecting bone marrow and blood cell development. Arpan Parichha, MD discusses the disease’s…
Recent Videos in CML Content Hub Page 2
Selecting CML Patients Eligible for Treatment Cessation
CML Content Hub
Susanne Saussele, MD, discusses #treatment #discontinuation in #CML.
Votobatinib Promising in Phase 1/2 Trial of Mostly Heavily Pretreated CML Patients
CML Content Hub
@GCC_Cortes, of @GACancerCenter, discusses #votobatinib in #CML.
Managing Long-Term Toxicities in Pediatric CML-CP
CML Content Hub
Nirmalya Roy Moulik, MD, PhD, of @TataMemorial, discusses #chronic #phase #CML in #pediatric patients.
Managing Challenging CML Cases
CML Content Hub
Susanne Saussele, MD, discusses #monitoring after #treatment #discontinuation in #CML.
Mitochondrial Metabolism Inhibitors as a CML Treatment?
CML Content Hub
@VignirHelgason, of @UofGlasgow, discusses #mitochondrial #metabolic #inhibitors for #CML.
Risk Stratifying CML Patients for Cardiovascular Adverse Events When Choosing First-Line Therapy
CML Content Hub
@mjmauroMD, of @MSKCancerCenter, discusses #risk stratification and #TKI selection in #CML.
5-Year Results Solidify Bosutinib’s Increased Efficacy vs Imatinib
CML Content Hub
@GCC_Cortes of @GACancerCenter discusses #bosutinib in #CML.
Optimizing CML Treatment: Latest Clinical Trial Data on TKI Efficacy and Dosage
CML Content Hub
@CoplandMhairi, of @UofGlasgow, discusses #TKI efficacy and #dosage.
CML Management and Emerging Therapies
CML Content Hub
Ehab Atallah, MD, of @MedicalCollege, and @mjmauroMD, of @MSKCancerCenter, discuss #emerging #therapies for #CML.
Nilotinib Therapy in Frontline CML
CML Content Hub
Timothy Hughes, of SAHMRI, discusses #frontline #nilotinib therapy in #CML.